# Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline

> **NCT01435213** · PHASE1 · COMPLETED · sponsor: **University of Turku** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Atipamezole
- **DRUG:** Atomoxetine
- **DRUG:** Ketamine
- **OTHER:** Cold pressor test
- **DRUG:** Insulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01435213
- **Lead sponsor:** University of Turku
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435213, "Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01435213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*